Sulfamethoxazole and Trimethoprim Tablets, 800 mg/160 mg, DOUBLE STRENGTH, Rx, packaged and labeled to contain Sulfamethoxazole and Trimethoprim Tablets, 400 mg/80 mg, Repackaged By: Shamrock Medical Solutions Lewis Center, Ohio, Mfg: Amneal/Interpharm, NDC 53746-272-01
Published July 30, 2014 · Recall initiated: September 27, 2011
Summary
FDA records drug Class II recall D-1450-2014, published July 30, 2014 and initiated September 27, 2011. Recalling firm: Shamrock Medical Solutions Group LLC; Status: Terminated; Reported quantity: 284/800 mg tablets; Lot: Lot 00288N, Use By: 9/15/2012, NDC 53746-272-01. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label Mix up; product labeled to contain Sulfamethoxazole and Trimethoprim Tablets, 400 mg/80 mg instead of Sulfamethoxazole and Trimethoprim Tablets, 800 mg/160 mg
What to do
Voluntary: Firm initiated · Telephone
Get an email if SULFAMETHOXAZOLE AND TRIMETHOPRIM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- SULFAMETHOXAZOLE AND TRIMETHOPRIM
- Manufacturer
- Shamrock Medical Solutions Group LLC
- Distributor
- Product was shipped to the following states: CO, MA, OH, TX & WY.
- UPC
- 0353746271013
- Lot
- Lot 00288N, Use By: 9/15/2012, NDC 53746-272-01
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASulfamethoxazole and Trimethoprim Tablets, USP 800mg / 160mg Double Strength packaged in a) 6-count bottlesSeptember 24, 2025
- FDASulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg, Double Strength, 100 Tablets unit dose blister packsSeptember 17, 2025
- FDASulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg, Double Strength, 10 Tablets unit dose blister packSeptember 17, 2025
- FDASulfamethoxazole and Trimethoprim Tablets, USP 800mg/160mg, Double Strength, Rx Only, Packaged as a) 100-countSeptember 10, 2025
- FDAPramipexole Dihydrochloride Tablets, 0.5 mg, Rx, packaged and labeled to contain Nebivolol tablets, RepackagedJuly 30, 2014
- FDADocusate Calcium Softgel Capsules, 240 mg, OTC, packaged and labeled to contain Docusate Sodium 240mg,July 30, 2014
Questions about this recall
Was Sulfamethoxazole and Trimethoprim Tablets, 800 mg/160 mg, DOUBLE STRENGTH, Rx, packaged and labeled to contain Sulfamethoxazole and Trimethoprim Tablets, 400 mg/80 mg, Repackaged By: Shamrock Medical Solutions Lewis Center, Ohio, Mfg: Amneal/Interpharm, NDC 53746-272-01 recalled?
Yes. FDA published recall D-1450-2014 on July 30, 2014. Reported hazard: Labeling: Label Mix up; product labeled to contain Sulfamethoxazole and Trimethoprim Tablets, 400 mg/80 mg instead of Sulfamethoxazole and Trimethoprim Tablets, 800 mg/160 mg
What should I do if I have this product?
Voluntary: Firm initiated · Telephone
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: SULFAMETHOXAZOLE AND TRIMETHOPRIM. UPC: 0353746271013.